FDA Peptide Reclassification 2026: What It Means for Providers Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 5mg Bluebonnet Source LLC BPC 157, 500 mcg, 60 Capsules